A paper using QPatch Compact was announced from a laboratory at Harvard Medical School, demonstrating the potential of VX-150 and VX-548 to target the Nav1.8 ion channel for pain relief.
ソフィオンバイオサイエンス
The paper using QPatch Compact focuses on the study of the inhibition of the Nav1.8 ion channel by two new analgesic compounds, VX-150 and VX-548. The Nav1.8 channel is a major target in sensory neurons that detect pain and is extremely important for pain-related therapies. This research, conducted by a professor's laboratory at Harvard Medical School, utilized the QPatch Compact semi-automated patch clamp system to perform voltage clamp recordings and analyze the effects of these compounds on Nav1.8 sodium currents. For more details, please see the related links.
